Documents & Downloads

ATP Synthesis-IN-3

ATP Hydrolysis Inhibitor

ATP Synthesis-IN-3 is an ATP hydrolysis inhibitor that exhibits protective effects during myocardial ischemia. This compound enhances ATP levels in ischemic cardiomyocytes and promotes the phosphorylation of protein kinase A (PKA) and phospholamban, thereby inhibiting apoptosis induced by ischemic conditions. It serves as a valuable tool for research in cardiac protection and cellular energy metabolism.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	3032416-36-4
Applications	ATP Hydrolysis Inhibitor
Formula	C₃₅H₃₉N₇O₂
Molecular Weight	589.73
SMILES	CN1CCN(C2=CC=C(NC3=NC(N4CCOCC4)=C5C(C(C6=CC=CC=C6)=NN5CC7=CC=C(C=C7)OC)=C3)C=C2)CC1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.